Regulatory & Legal

A new report reveals a startling trend: fewer recall events are leading to a massive 27% surge in recalled units, signaling larger, more dangerous defects.

Infoblox and GoDaddy are championing open standards using DNS to create a vital identity and verification layer for the coming wave of AI agents.

A new partnership uses AI to eliminate costly subjectivity in brain disorder research, promising to accelerate new treatments and improve data integrity.

A new wave of MedTech innovators is ditching fragmented systems for unified, AI-driven platforms, accelerating life-saving device development. Here's why.

With $5M in funding, a new defense startup aims to solve the Navy's cost crisis by building affordable interceptors to counter cheap enemy drones.

Qualys's TotalCloud achieves the government's top security clearance, enabling federal agencies to accelerate secure cloud adoption and combat threats.

OrganOx names Terumo's Naoya Iwata as new CEO, signaling a major push to expand its life-saving organ transplant technology across the globe.

A federal jury exonerated hedge fund Armistice Capital of all fraud claims related to Vaxart's COVID-era stock surge, a major trial loss for investors.

Natrol launches Ultra Sleep and Energy, partnering with Calm and Michelle Monaghan in a bold move to connect restorative rest with daytime vitality.

As AI risks mount, a new alliance between AIQA Global and SecureSky signals a market shift toward integrated governance and security to meet regulatory demands.

Drowning is a leading, often silent, cause of death for kids. As rates rise, the Red Cross is launching new Spanish-language resources to bridge a deadly gap.

Atamyo's new gene therapy shows remarkable early results, potentially halting a severe, progressive muscular dystrophy that affects children.

Israel's top bank reports NIS 2.1B profit, showcasing economic resilience amid conflict and regulatory pressure while rewarding shareholders with dividends.

As AI's power demands strain global grids, PowerX's new battery system aims to turn data centers from consumers into revenue-generating grid partners.

A landmark clinical trial shows umbilical cord blood can safely reduce debilitating back pain, opening a new frontier beyond traditional stem cell uses.

Malaysian aquaculture firm Megan Holdings' stock has plummeted, triggering a Nasdaq delisting warning and a six-month race to regain compliance.

New Pacific Metals reports a Q3 net loss but holds a strong $39M in capital, securing a crucial community agreement for its Carangas project in Bolivia.

Insurtech leader Ethos releases a significant block of shares, providing liquidity to early backers and setting up a major test for the stock and the sector.

With strong HIFU revenue and new clinical trials, EDAP TMS's upcoming Investor Day will reveal its strategy for medtech dominance and investor confidence.

A new six-month semaglutide implant is entering clinical trials, aiming to solve the adherence crisis plaguing GLP-1 drugs like Ozempic and Wegovy.